Cerus Corporation (CERS) Social Stream



Cerus Corporation (CERS): $1.56

0.04 (+2.63%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add CERS to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#65 of 329

in industry

CERUS CORP (CERS) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CERS.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 4 $11.5 $7 $9.625 $1.96 391.07%
2022-02-24 4 $11.5 $8.5 $10 $1.96 410.2%
2022-05-09 3 $11.5 $7.5 $9.75 $1.96 397.45%
2022-06-01 4 $11.5 $7.5 $9.75 $1.96 397.45%
2022-08-08 3 $11.5 $7.5 $9.666 $1.96 393.16%
2022-11-08 3 $11.5 $6 $9.166 $1.96 367.65%
2022-12-01 4 $11.5 $6 $9.166 $1.96 367.65%
2023-02-03 4 $11.5 $3.75 $8.812 $1.96 349.59%
2023-02-28 4 $11.5 $3.75 $8.062 $1.96 311.33%
2023-03-02 4 $11.5 $3.75 $7.812 $1.96 298.57%
2023-03-03 4 $11.5 $3.5 $7.75 $1.96 295.41%
2023-05-10 4 $11.5 $3.25 $7.687 $1.96 292.19%
2023-06-01 4 $11.5 $3 $7.166 $1.96 265.61%
2023-07-11 4 $11.5 $3 $7.625 $1.96 289.03%
2023-08-02 4 $11.5 $3 $7.375 $1.96 276.28%
2023-11-06 4 $9 $3 $5.75 $1.96 193.37%
2023-12-01 4 $6 $2.5 $4.125 $1.96 110.46%

The Trend in the Analyst Price Target


Over the past 43 months, CERS's average price target has gone down $3.88.

CERS reports an average of 201.84% for its upside potential over the past 45 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-02 4 11.5 3.50 7.750 2.800 176.79%
2023-03-02 4 11.5 3.75 7.812 2.800 179%
2023-05-01 4 11.5 3.25 7.687 2.350 227.11%
2023-05-04 4 11.5 3.25 7.687 2.310 232.77%
2023-08-02 4 11.5 3.00 7.375 2.975 147.9%

CERS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 3 0 1 0 0 4

The Trend in the Broker Recommendations


CERS's average broker recommendation rating improved by 0 over the prior 26 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • CERS has a higher average analyst price target than 155.99% of all US stocks.
  • CERS has a higher upside potential (average analyst target price relative to current price) than 1718.54% of all US stocks.
  • In terms of how CERUS CORP fares relative to all US stocks, note that its number of analysts covering the stock is greater than 235.9% of that group.
  • In terms of how CERUS CORP fares relative to Medical Equipment stocks, note that its variance in analysts' estimates is lower than -1403.17% of that group.

Stocks similar to CERUS CORP in the Medical Equipment industry regarding analyst recommendations and price targets are RVP, SRDX, and ANIK.

Is CERS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!